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A B S T R A C T
A retrospective study was undertaken to analyse the risk factors for systemic emboli in infective
endocarditis. Patients (n ¼ 80; 70% males; mean age 65 years; range 20–91 years) with infective
endocarditis, as defined by the Duke criteria and diagnosed using transoesophageal echocardiography
during the period January 1995 to March 2001, were included. The average time between the start of the
illness and the beginning of antibiotic treatment was 55 days (range 0–405 days). The pathogens
identified were streptococci (n ¼ 47), staphylococci (n ¼ 11), enterococci (n ¼ 9), and others (n ¼ 4). In
nine cases, blood cultures were sterile. Thirty patients with at least one embolic episode were compared
with 50 control patients. According to univariate analysis, the main risk factor for systemic emboli was
the size of the vegetation (12.4 mm vs. 7.8 mm; p ¼ 0.0005). The risk of emboli was 57% when the
vegetation measured > 10 mm and only 22% when it was < 10 mm (p ¼ 0.003). The mobility of the
vegetation was also a risk factor: 48% if the vegetation was mobile; and 9% if fixed (p ¼ 0.003). Sex, age,
pathogen, antibiotic treatment, type of valve and the number and position of the vegetations were not
found to be risk factors. With multivariate analysis, only mobility was identified as a risk factor. Overall,
mobile vegetations > 10 mm in size were associated with an increased risk of embolic episodes in
infective endocarditis.
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I N T R O D U C T I O N
The prognosis of infective endocarditis, even with
appropriate antibiotic therapy, is poor, with a
9–30% global mortality rate [1–4]. The complica-
tions leading to death are principally cardiac
insufficiency, accounting for c. 40% of cases and
60% of mortality, strokes caused by emboli, rather
than rupture of aneurysm, which account for 40%
of reported cases and 20% of deaths, and persist-
ent sepsis despite adequate antibiotic treatment
[5,6], which is now rather rare. Emboli, seen in
c. 40% of cases, regardless of location [5], may
require surgery in cases of recurrence, notwith-
standing appropriate treatment [7]. However, in
cases of ischaemic cardiovascular accidents, sur-
gery would carry a high risk of haemorrhage
because of the anticoagulation measures needed
for extracorporeal circulation [7]. Numerous
authors have tried to establish the predictive
factors for emboli, but their results are contra-
dictory, particularly with regard to the embolic
risk linked to a large, mobile vegetation. Accord-
ing to some, the larger the vegetation, the more
frequent the embolic risk [8–11], but this opinion
is not substantiated by others [1,3,4]. For this
reason, a retrospective study was carried out to
analyse the risk factors for systemic emboli
(individual factors, cerebral localisation and type
of valve, pathogen, treatment) and, in particular,
the roles of both the size and mobility of the
vegetation.
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P A T I E N T S A N D M E T H O D S
This was a retrospective study of 80 patients with infective
endocarditis, hospitalised in either the infectious diseases,
internal medicine or cardiology departments of the University
Hospital of Saint Etienne or the Hospital of Roanne, France,
between January 1995 and March 2001. Patients with at least
one embolic episode were compared to those with no embolic
history.
The diagnosis of infective endocarditis was made using
the Duke criteria [12]. Only patients in whom transoesopha-
geal echocardiography (TEE) showed a vegetation on a
cardiac valve were retained in the study. The measurements
taken during TEE were also the only ones taken into
consideration.
The vegetations were measured in two orthogonal dimen-
sions; one measurement was made perpendicular to the leaflet
surface, and the second was parallel. Each measurement was
made at the point of maximal thickness. A non-mobile
vegetation was defined as a vegetation with no detectable
independent motion, and a mobile vegetation was defined as a
vegetation with a free mobile edge.
The following clinical and ⁄ or radiological localisations
were considered to be embolic symptoms: cutaneous isch-
aemia (Janeway’s lesions); and an infarct in any organ
(principally in brain, spleen and kidney), but also pulmonary
infarction in cases of right-sided infective endocarditis. Symp-
toms known to be of immunological origin (glomerulonephri-
tis, aseptic arthritis, Osler’s nodes), as well as secondary
pyogenic localisations (spondylitis with discitis and abscesses),
were excluded.
The antibiotic treatment was considered to be adequate
when given in accordance with the recommendations of the
American Heart Association, as closely followed by French
practitioners [13]. The starting point of the illness was
defined by interrogating the patient about his first symp-
toms (e.g., fever, emboli or pain resulting from an embolic
episode).
The chi-square test was used for qualitative comparisons,
and ANOVA for quantitative variables. The 95% confidence
intervals for odds ratios were calculated by the Cornfield
method. The actuarial survival curves were created with the
log-rank and Breslow–Gehaan–Wilcoxon tests. The software
used was Epi-info v.6.0 (Centers for Disease Control,
Atlanta GA, USA) and StatView v.5 (SAS Institute; Cary,
NC, USA).
The association of emboli and above-average vegetation
size was tested as described previously [9]. TEE measure-
ments were used to determine the sensitivity, specificity,
and the positive predictive values (PPVs) and negative
predictive values (NPVs), according to the following defi-
nitions: sensitivity ¼ number of patients with an embolus
and a vegetation of greater than mean size ‚ total number
of patients with an embolic episode; specificity ¼ number of
patients with no embolus and a vegetation of less than
mean size ‚ total number of patients without an embolic
episode; PPV ¼ number of patients with an embolus and a
vegetation of greater than mean size ‚ total number of
vegetations of greater than mean size; NPV ¼ number of
patients with no embolus and a vegetation of less than
mean size ‚ total number of vegetations of less than mean
size.
R E S U L T S
Characteristics of patient population
Eighty patients (30% female; mean age 65 years;
range 20–91 years) with infective endocarditis
and positive findings on echocardiography were
studied. The average time lapse between the
presumed onset of the disease and the start of
antibiotic treatment was 45 days (median,
22 days), and 55 days (median, 23 days) were
needed for adequate antibiotic treatment.
In 72 (90%) patients, the infective endocarditis
appeared on a native valve, in seven (9%)
patients on a mechanical prosthesis, and in one
(1%) patient on a homologous graft. Thirty
(38%) patients experienced at least one embolic
episode.
The average size of the vegetations was
9.5 mm, which was rounded up to 10 mm. The
size of the vegetation in the seven (9%) patients
who died was greater than in patients who
survived, although there was no statistical corre-
lation between death and the size of the veget-
ation. Among the seven patients who died, six
experienced at least one systemic embolus. The
deaths were mostly caused by cardiogenic shock
(n ¼ 4) (Table 1).
Thirty patients had undergone valve replace-
ment surgery. Fourteen cases required surgery
because of extensive valve destruction, inclu-
ding multiple emboli (n ¼ 6), cardiogenic shock
(n ¼ 5), a large vegetation (n ¼ 3), and other
factors (n ¼ 2).
Site and timing of emboli
The brain was the site most frequently affected by
emboli (34%), followed by spleen (27%), skin
(22%), kidney (7%), coronary artery (5%) and
lungs (5%). Emboli occurred within 10 days of
the start of the disease (40%) and before the start
of any antibiotic treatment (73%) (Fig. 1).
Pathogens
Table 2 shows the pathogens that were responsible
for infective endocarditis. The most frequent were
streptococci (59%) and staphylococci (14%). There
was no correlation between the type of pathogen
and the occurrence of embolic episodes; of those
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patients infected by enterococci, 33% had emboli,
compared with 36% of patients with staphylo-
cocci, 45% of patients with streptococci, and 22%
of patients with sterile blood cultures (p ¼ 0.35).
Risk factors for emboli
Factors that could predict the onset of an embolic
episode were investigated. In the present series,
the age, sex, location and type of valve affected,
initial antibiotic treatment, evolution of the veget-
ation and its size 4 weeks after the initial echo-
cardiography and the number of vegetations did
not appear to be risk factors for an embolic
episode (Table 3).
However, vegetation size (Fig. 2) and mobility
did appear to be risk factors for emboli (Table 3).
The most mobile vegetations were also the largest;
the average size of the mobile vegetations was
11.4 mm vs. 4.54 mm for the non-mobile vegeta-
tions (p < 0.0001).
When a threshold figure of 10 mm above which
patients were at high risk of systemic emboli was
fixed, the following values were obtained: sensi-
tivity 67%; specificity 70%; PPV 57%; and NPV
78% (Table 4). In relation to mobile vegetations
> 10 mm in size, the values were: sensitivity 71%;
specificity 60%; PPV 63%; and NPV 69%.
Embolic episodes are often indicators of infec-
tive endocarditis, and the first TEE is there-
fore often performed rather belatedly. If the
17 patients who underwent TEE after the occur-
rence of the embolic episode were excluded, then
mobility and vegetation size remained risk factors
(Table 5).
Table 2. Distribution of bacteria isolated in infective
endocarditis
Organism No. %
Streptococcus 47 59
Streptococcus bovis 23
Streptococcus oralis 7
Streptococcus mitis 3
Streptococcus agalactiae 3
Streptococcus sanguis 3
Streptococcus mutans 2
Streptococcus gordonii 2
Streptococcus anginosus 1
Streptococcus constellatus 1
Streptococcus defectivus 1
Streptococcus spp. 1
Staphylococcus 11 14
Staphylococcus aureus, methicillin-resistant 1
Staphylococcus aureus, methicillin-sensitive 5
Staphylococcus epidermidis 3
Staphylococcus lugdunensis 1
Staphylococcus warneri 1
Corynebacterium 1 1
Escherichia coli 1 1
Enterococcus 9 11
Erysipelothrix rhusiopathiae 1 1
Propionibacterium acnes 1 1
Sterile blood culture 9 11
Total 80
Table 1. Comparison of size of the
vegetations and emboli in patients
who died or survived
Died Survived
Mean size of the vegetation (mm) 15.9 8.9 p ¼ 0.015
Size of the vegetation
> 10 mm 5 (14%) 30 (86%) p: NS
< 10 mm 2 (4%) 43 (96%)
Emboli 6 (86%) 24 (33%) p ¼ 0.019
No emboli 1 (14%) 49 (67%) OR 12.2 (1.3–28.5)
Causes of death
Four deaths from cardiogenic shock
One death from septic shock
Two unexpected deaths
NS, not statistically significant; OR, odds ratio.
Fig. 1. Time elapsed before occurrence of emboli.
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If the eight patients with valve prostheses were
excluded, the risk factors for systemic emboli were
identical. However, there was still no evidence
that the diseased valve was a risk factor (Table 6).
Actuarial survival
When actuarial survival was considered, the size
of the vegetation was a risk factor for an embolic
episode. This occurred both more frequently and
sooner in cases where the vegetation was
> 10 mm in size (Fig. 3).
Multivariate analysis
With multivariate analysis, only the mobility of
the vegetation appeared to be a risk factor for an
embolic episode, with an odds ratio of 10.39 (1.20–
89.8), p ¼ 0.003.
D I S C U S S I O N
Even though the antibiotic treatments for infec-
tive endocarditis are well-documented [13], the
indications for and the timing of surgery still
pose problems. The principal dilemma is whe-
ther to operate early to limit the risk of emboli
and ⁄ or to avoid eventual severe cardiac insuffi-
ciency, or to delay surgical intervention after
the episode of infection to reduce the risks of
surgery. Moreover, replacement of valves
implies anticoagulation for life as well as the
risk of a further infective episode involving the
mechanical valve.
In some previous reports, the size of the
vegetation was a risk factor for embolic episodes
regardless of aetiology [10], while in others this
was only true when the microorganism was a
streptococcus [8]. Others have stated that there is
Table 3. Risk factors for the occur-
rence of an embolic episode Emboli No emboli
Sex
Female 10 (42%) 14 (58%) NS
Male 26 (46%) 30 (54%)
Age at start of illness 64 years 65 years NS
Initial antibiotherapy
Adapted 25 (38%) 41 (62%) NS
Not adapted 5 (36%) 9 (64%)
Time lapse before start
of adapted antibiotherapy
Mean 66 days 48 days NS
Median 33 days 26 days NS
Affected valves
Aortic 8 (26%) 23 (74%) NS
Mitral 15 (40%) 23 (60%)
Tricuspid 2 (50%) 2 (50%)
Mitral + aortic 5 (72%) 2 (28%)
Valve type
Native 25 (35%) 47 (65%) NS
Prosthesis 5 (62%) 3 (38%)
Evolution of the size of the
vegetation 4 weeks later
Increased 4 (67%) 2 (33%) NS
Decreased 11 (48%) 12 (52%)
Stable 8 (32%) 17 (68%)
Number of vegetations
1 19 (33%) 39 (67%) NS
2 5 (42%) 7 (58%)
> 3 6 (60%) 4 (40%)
Mobility of vegetation
Mobile 28 (48%) 30 (52%) p ¼ 0.003
Fixed 2 (9%) 20 (91%) OR ¼ 9.3 (1.8–63.7)
Mean size of vegetation (mm) 12.4 7.8 p ¼ 0.005
Size of vegetation
> 10 mm 20 (57%) 15 (43%) p ¼ 0.003
< 10 mm 10 (22%) 35 (78%) OR ¼ 4.7 (1.6–13.9)
NS, not statistically significant; OR, odds ratio.
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no correlation between the size of the vegetation
and the embolic risk [1,3,4,14,15]. All these stud-
ies only used transthoracic echocardiography;
however, Mu¨gge et al. [9] found a significant
statistical correlation between a vegetation
> 10 mm in size on the mitral valve and embolic
risk by measuring the vegetations using TEE.
Other authors have also found a similar correla-
tion using transthoracic echocardiography
[16–18], and these results have been confirmed
by a meta-analysis [19]. Lancellotti et al. [20]
reported that the embolic risk was increased only
for vegetations > 14 mm in size, but the study
included only 45 patients.
In the present study, all the vegetations were
measured using TEE, and an increased risk of
emboli was identified when the vegetation was
> 10 mm in size, regardless of the aetiology or the
valve involved. From the actuarial survival
curve, it appeared that the embolic risk is both
greater and occurs earlier for vegetations
> 10 mm in size than for those < 10 mm. It would
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Fig. 2. Cumulative probability of
embolic episodes in the studied
population (including the 17 pa-
tients who had emboli before the
first TEE).
Table 5. Risk factors of systemic
emboli after exclusion of the 17
patients who presented with an
embolus before the initial trans-
oesophageal echocardiography
Emboli No emboli
Mobility of vegetation
Mobile 13 (30%) 30 (70%) p ¼ 0.022
Fixed 0 (0%) 20 (100%) OR ¼ 8.7 (1.02–191.3)
Mean size of vegetation (mm) 12.1 7.8 p ¼ 0.017
Size of vegetation
> 10 mm 9 (38%) 15 (62%) p ¼ 0.022
< 10 mm 4 (10%) 35 (90%) OR ¼ 5.25 (1.2–24.5)
OR, odds ratio.
Table 4. Association between embo-
lic episodes and vegetation size
> 10 mmTotal
population
Patients without embolic
episodes before the
echocardiography
Emboli with vegetation > 10 mm 20 9
No emboli with vegetation > 10 mm 15 15
No emboli with vegetation < 10 mm 35 35
Emboli with vegetation < 10 mm 10 4
Sensitivity 67% 69%
Specificity 70% 70%
Positive predictive value 57% 38%
Negative predictive value 78% 90%
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be interesting to determine a threshold value
above which the embolic risk becomes very
important, but the sizes of the vegetations seen
in the present study did not extend over a
sufficient range and were not sufficiently homo-
geneous to allow us to analyse the data [21].
Therefore, the threshold was fixed at 10 mm, as
this was the average size of all the vegetations. In
defining this threshold for detecting patients
with a high risk of systemic emboli, it was found
that the sensitivity, specificity, PPV and NPV
figures were similar to those reported by Mu¨gge
et al. [9], even after excluding the 17 patients
whose disease was revealed by the embolic
episode and for whom TEE was therefore only
performed after the embolic episode.
In the present study, the mobility of the
vegetation was also a risk factor for emboli, but
this was closely correlated with size, since the
largest vegetations are also the most mobile.
These results are in agreement with those pub-
lished previously [11,22]. As this was a retrospec-
tive study and the evaluation criteria had not
been decided in advance, it was not possible to
evaluate the risk of emboli as a function of the
surface area of the vegetation, a risk factor
documented by Cabell et al. [23].
In the literature, the development of the size of
the vegetation over time seemed to be a prognos-
tic factor for the severity of infective endocarditis
[8,24]. This risk factor was not identified in the
present series, but only 54 (68%) patients had a
TEE control performed 4 weeks later. This num-
ber was probably too small to show a significant
statistical difference.
There was a high (38%) level of emboli in the
present series compared with those reported in
the literature (19–30%) [3,4,10]. This was probably
because only those patients with at least one
vegetation on TEE were included in the present
study, whereas numerous other studies included
patients with no visible vegetations on echocar-
diography. If, in these studies, the rate of emboli
in the subgroups with visible vegetations is
analysed, then similar rates of 40–50% are calcu-
lated [1,8,15].
Table 6. Risk factors for systemic
emboli in patients with infective
endocarditis affecting native valves
Emboli No emboli
Affected valve
Aortic 7 (25%) 21 (75%) NS
Mitral 11 (33%) 22 (67%)
Tricuspid 2 (50%) 2 (50%)
Mitral + aortic 5 (72%) 2 (28%)
Mobility of vegetation
Mobile 23 (44%) 29 (56%) p ¼ 0.020
Fixed 2 (10%) 18 (90%) OR ¼ 7.1 (1.4–49.7)
Mean size of vegetation (mm) 11.2 8.4 p ¼ 0.031
Size of vegetation
> 10 mm 17 (53%) 15 (47%) p ¼ 0.007
< 10 mm 8 (20%) 32 (80%) OR ¼ 4.5 (1.43–14.77)
NS, not statistically significant; OR, odds ratio.
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Fig. 3. Actuarial survival: embolic
risk according to the size of the
vegetation.
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Depending on the study, there either exists
[1,19] or does not exist [4,9,10] a correlation
between the size of the vegetation and mortality.
A correlation was identified in the present study
between a higher mortality rate and increased
vegetation size. On the other hand, when the
threshold level was set at 10 mm for systemic
emboli, no correlation was found, but this is based
on only seven deaths. Contrary to some previous
studies [8–10], but in agreement with Steckelberg
et al. [15], the present study did not find any
significant statistical correlation between embolic
risk and the valve involved. Similarly, in contrast
to some studies [1,3,15], no correlation was
observed between the infecting microorganism
and embolic risk. Antibiotic treatment seemed to
influence the size of the vegetation [24], but in the
present retrospective study it was not possible to
analyse this aspect.
In agreement with most other studies [8,9,15],
there was a strong prevalence of emboli occur-
ring within 15 days of the onset of disease,
often leading to the diagnosis of infective
endocarditis. This could represent a biased
result, as the first echocardiography was often
performed after the embolic episode, and the
size of the vegetation may have been underes-
timated. For this reason, the statistical calcula-
tions for the subgroup of patients who had an
embolic episode after echocardiography were
repeated, but the size of the vegetation and its
mobility were still identified as risk factors for
systemic emboli.
The sensitivity and specificity of TEE for
identifying valve vegetations vary in the cited
studies from 82–100% and 91–100%, respectively,
to 10–63% and 91–98% [25–27] for transthoracic
echocardiography. Only TEE was used in the
present study, decreasing the risk of biased
results through incorrect estimation of the veget-
ation size. However, one of the limitations of this
type of retrospective study is the inter- and intra-
observer variability in the measurement of veget-
ation size and mobility. Furthermore, numerous
asymptomatic embolic episodes, particularly
those affecting the spleen, have not been taken
into account in the retrospective studies. Only
a prospective study, using systematic clinical
research and medical imaging of the emboli,
particularly splenic and renal emboli, could elim-
inate bias in the final data. Finally, 24 patients
had early valve replacement surgery for reasons
unconnected with the emboli, which probably
decreased their risk of a later embolic episode.
A multivariate analysis according to the Cox
model was not carried out. This is only possible
where the risk to the patient remains proportional
over time, which was not the case in the present
study, since the risk of emboli is at a maximum
during the first 2 weeks [8,9,15]. With the use of
logistic regression, only the mobility of the veget-
ation, and not its size, appeared as a risk factor for
emboli. This result may be explained by an
insufficient number of patients to allow identifi-
cation of size as an independent risk factor for
embolic episodes.
Many (40%) emboli began within 10 days of
the onset of symptoms, and 75% occurred before
the onset of therapy. Embolisation became less
frequent with longer duration of therapy, as
previously reported [8,15,28]. According to
Mu¨gge [29], it appears that early diagnosis with
initiation of adequate antibiotic therapy is still the
best way to prevent embolic complications.
The present study confirmed that a mobile
vegetation > 10 mm in size, measured using TEE,
puts the patient at increased risk from embolic
episodes. In view of the accumulation of data
establishing this risk factor, it seems urgent to
undertake a prospective study to evaluate the
connection between the gains and risks of surgi-
cal intervention vs. early antibiotic therapy in
cases where the vegetation falls within this
category.
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